Drug & Medication Database
Browse 18,617 FDA-approved medications with detailed information about uses, dosage, side effects, and interactions.
Olopatadine Hydrochloride Ophthalmic
olopatadine hydrochloride ophthalmic
Active Ingredient Purpose Olopatadine (0.1%). (equivalent to olopatadine hydrochloride 0.111%) Antihistamine and redness reliever
Brands: Olopatadine Hydrochloride
Olopatadine Hydrochloride Ophthalmic Solution
olopatadine hydrochloride ophthalmic solution
Purpose Antihistamine and Redness Reliever
Brands: Rugby Olopatadine Hydrochloride Ophthalmic Solution
Olsalazine Sodium
olsalazine sodium
11 DESCRIPTION The active ingredient in DIPENTUM (olsalazine sodium) is the sodium salt of a salicylate, disodium 3,3'-azobis (6-hydroxybenzoate) a compound that is effectively bioconverted to mesalamine (5-aminosalicylic acid,5-ASA), an aminosalicylate. Its empirical formula is C14H8N2Na2O6 with a molecular weight of 346.21. The structural formula is: Olsalazine sodium is a yellow crystalline powder, which melts with decomposition at 240°C.
Brands: Dipentum
Olutasidenib
olutasidenib
11 DESCRIPTION Olutasidenib is an isocitrate dehydrogenase-1 (IDH1) inhibitor. The chemical name is (S)-5-((1-(6-chloro-2-oxo-1,2-dihydroquinolin-3-yl)ethyl)amino)-1-methyl-6-oxo-1,6-dihydropyridine-2-carbonitrile. The chemical structure is: The molecular formula is C 18 H 15 ClN 4 O 2 and the molecular weight is 354.79 g/mol. Olutasidenib is a white to off-white to brown powder that is practically insoluble in aqueous solutions between pH 1.2 and 7.4.
Brands: Rezlidhia
Omacetaxine Mepesuccinate
omacetaxine mepesuccinate
Manufactured by TEVA PHARMS INTL. Dosage form: POWDER. Route: SUBCUTANEOUS. Active ingredients: OMACETAXINE MEPESUCCINATE (3.5MG/VIAL). Application: NDA203585.
Omadacycline
omadacycline
11 DESCRIPTION NUZYRA contains omadacycline tosylate, an aminomethylcycline which is a semisynthetic derivative of the tetracycline class of antibacterial drugs, for intravenous or oral administration. The chemical name of omadacycline tosylate is (4S,4aS,5aR,12aS)-4,7-bis(dimethylamino)-9-(2,2-dimethylpropylaminomethyl)-3,10,12,12a-tetrahydroxy-1,11-dioxo-1,4,4a,5,5a,6,11,12a-octahydrotetracene-2-carboxamide, 4-methylbenzenesulfonate.
Brands: Nuzyra
Omadacycline Tosylate
omadacycline tosylate
Dosage form: POWDER. Active ingredients: OMADACYCLINE TOSYLATE (1 kg/kg). Category: BULK INGREDIENT.
Omalizumab
omalizumab
11 DESCRIPTION Omalizumab is a recombinant DNA-derived humanized IgG1κ monoclonal antibody that selectively binds to human immunoglobulin E (IgE). The antibody has a molecular weight of approximately 149 kiloDaltons. XOLAIR is produced by a Chinese hamster ovary cell suspension culture. XOLAIR (omalizumab) is administered as a subcutaneous (SC) injection and is available in prefilled syringe, autoinjector and in vials.
Brands: Xolair, Xolair Pfs, Xolair
Omalizumab-igec
omalizumab-igec
11 DESCRIPTION Omalizumab-igec is a recombinant DNA-derived humanized IgG1κ monoclonal antibody that selectively binds to human immunoglobulin E (IgE). The antibody has a molecular weight of approximately 149 kiloDaltons. Omalizumab-igec is produced by a Chinese hamster ovary cell suspension culture. Omalizumab-igec is administered as a subcutaneous (SC) injection and is available in prefilled syringes.
Brands: Omalizumab-igec
Omaveloxolone
omaveloxolone
11 DESCRIPTION SKYCLARYS contains omaveloxolone in immediate release capsules for oral administration available in a 50 mg strength. The chemical name of omaveloxolone is N-(2-cyano-3,12-dioxo-28-noroleana-1,9(11)-dien-17-yl)-2,2-difluoro-propanamide. Omaveloxolone is a white to off-white amorphous solid. The molecular formula is C 33 H 44 F 2 N 2 O 3 . Molecular weight is 554.72 g/mol.
Brands: Skyclarys
Omberacetam
omberacetam
Dosage form: POWDER. Active ingredients: OMBERACETAM (1 g/g). Category: BULK INGREDIENT.
Ombitasvir
ombitasvir
Manufactured by ABBVIE. Dosage form: TABLET, EXTENDED RELEASE. Route: ORAL. Active ingredients: DASABUVIR SODIUM (EQ 200MG BASE); OMBITASVIR (8.33MG); PARITAPREVIR (50MG); RITONAVIR (33.33MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**). Application: NDA208624.
Ombitasvir, Paritaprevir, Ritonavir
ombitasvir, paritaprevir, ritonavir
Manufactured by ABBVIE. Dosage form: TABLET. Route: ORAL. Active ingredients: DASABUVIR SODIUM (EQ 250MG BASE); OMBITASVIR, PARITAPREVIR, RITONAVIR (12.5MG, 75MG, 50MG). Application: NDA206619.
Omecamtiv Mecarbil
omecamtiv mecarbil
Dosage form: POWDER. Active ingredients: OMECAMTIV MECARBIL (1 kg/kg). Category: BULK INGREDIENT.
Omega 3 Triglycerides
omega 3 triglycerides
Dosage form: OIL. Active ingredients: OMEGA-3 FATTY ACIDS (1 kg/kg). Category: BULK INGREDIENT.
Omega-3 Fish Oil
omega-3 fish oil
Dosage form: CAPSULE. Active ingredients: DOCONEXENT (200 mg/1); FISH OIL (1000 mg/1); ICOSAPENT (300 mg/1). Category: DRUG FOR FURTHER PROCESSING.
Omega-3-acid Ethyl Esters
omega-3-acid ethyl esters
Lipid-regulating agent supplied as liquid-filled gel capsules containing omega-3 fatty acid ethyl esters, primarily EPA and DHA. Used to reduce triglyceride levels in adults with severe hypertriglyceridemia.
Brands: Omega-3-acid Ethyl Esters
Omega-3-acid Ethyl Esters Capsules
omega-3-acid ethyl esters capsules
11 DESCRIPTION Omega-3-acid ethyl esters, USP a lipid-regulating agent, are supplied as a liquid-filled gel capsule for oral administration. Each 1-gram capsule of omega-3-acid ethyl esters, USP contains at least 900 mg of the ethyl esters of omega-3 fatty acids sourced from fish oils. These are predominantly a combination of ethyl esters of eicosapentaenoic acid (EPA — approximately 465 mg) and docosahexaenoic acid (DHA — approximately 375 mg).
Brands: Omega-3-acid Ethyl Esters
Omega-3-acid Ethyl Esters Type A
omega-3-acid ethyl esters type a
Manufactured by OSMOTICA PHARM US. Dosage form: CAPSULE. Route: ORAL. Active ingredients: OMEGA-3-ACID ETHYL ESTERS TYPE A (1.2GM CONTAINS AT LEAST 900MG OF THE ETHYL ESTERS OF OMEGA-3 FATTY ACIDS). Application: NDA204977.
Omega-3-carboxylic Acids
omega-3-carboxylic acids
Manufactured by ASTRAZENECA. Dosage form: CAPSULE. Route: ORAL. Active ingredients: OMEGA-3-CARBOXYLIC ACIDS (1GM CONTAINS AT LEAST 850MG OF POLYUNSATURATED FATTY ACIDS). Application: NDA205060.
Omega-3acid Ethyl Esters
omega-3acid ethyl esters
Manufactured by RELIANT PHARMS. Dosage form: CAPSULE. Route: ORAL. Active ingredients: OMEGA-3ACID ETHYL ESTERS (1G). Application: NDA021853.
Omepraole, Sodium Bicarbonate
omepraole, sodium bicarbonate
Purpose Acid reducer Allows absorption of this omeprazole product
Brands: Zegerid Otc
Omeprazole (form-b)
omeprazole (form-b)
Dosage form: POWDER. Active ingredients: OMEPRAZOLE (1 kg/kg). Category: BULK INGREDIENT.
Omeprazole 20 Mg
omeprazole 20 mg
PURPOSE Purpose Acid reducer
Brands: Omeprazole 20 Mg
Omeprazole 20mg
omeprazole 20mg
Purpose Acid reducer
Brands: Omeprazole Delayed Release
Omeprazole And Sodium Bicarbonate
omeprazole and sodium bicarbonate
Combination of omeprazole (proton-pump inhibitor) and sodium bicarbonate (antacid) in capsule form for the treatment of duodenal ulcers, gastric ulcers, GERD, and erosive esophagitis.
Brands: Omeprazole/bicarbonate
Omeprazole Fcmt
omeprazole fcmt
Dosage form: TABLET, DELAYED RELEASE PARTICLES. Active ingredients: OMEPRAZOLE MAGNESIUM (1 kg/kg). Category: DRUG FOR FURTHER PROCESSING.
Omeprazole Magnesium
omeprazole magnesium
Purpose Acid reducer
Brands: Prilosec Otc
Omeprazole Magnesium 20.6mg Capsules
omeprazole magnesium 20.6mg capsules
Purpose Acid reducer
Brands: Omeprazole Magnesium
Omeprazole Magnesium, Amoxicillin And Rifabutin
omeprazole magnesium, amoxicillin and rifabutin
11 DESCRIPTION TALICIA delayed-release capsules contain omeprazole magnesium, amoxicillin and rifabutin for oral administration. Omeprazole magnesium is included in the delayed-release component of the capsule, and amoxicillin and rifabutin are included in the immediate-release component of the capsule.
Brands: Talicia
Medical Disclaimer
This drug database is for informational purposes only. Drug information is sourced from the FDA National Drug Code Directory and Structured Product Labeling. Always consult with a healthcare provider before starting, stopping, or changing any medication.